dihydroethidium has been researched along with imidapril in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (imidapril) | Trials (imidapril) | Recent Studies (post-2010) (imidapril) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 238 | 62 | 38 |
| Protein | Taxonomy | dihydroethidium (IC50) | imidapril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 9.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, K; Ishimitsu, T; Matsuoka, H; Nishikimi, T; Takeda, Y | 1 |
1 other study(ies) available for dihydroethidium and imidapril
| Article | Year |
|---|---|
Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, Differentiation; Cell Differentiation; Drug Therapy, Combination; Ethidium; Imidazolidines; Macrophages; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Nephritis, Interstitial; Oxidative Stress; rho-Associated Kinases; Ureteral Obstruction | 2010 |